Influenza virus morphogenesis and budding. by Nayak, Debi P et al.
UCLA
UCLA Previously Published Works
Title
Influenza virus morphogenesis and budding.
Permalink
https://escholarship.org/uc/item/8p43p52w
Journal
Virus research, 143(2)
ISSN
0168-1702
Authors
Nayak, Debi P
Balogun, Rilwan A
Yamada, Hiroshi
et al.
Publication Date
2009-08-01
DOI
10.1016/j.virusres.2009.05.010
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
  
Since January 2020 Elsevier has created a COVID-19 resource centre with 
free information in English and Mandarin on the novel coronavirus COVID-
19. The COVID-19 resource centre is hosted on Elsevier Connect, the 
company's public news and information website. 
 
Elsevier hereby grants permission to make all its COVID-19-related 
research that is available on the COVID-19 resource centre - including this 
research content - immediately available in PubMed Central and other 
publicly funded repositories, such as the WHO COVID database with rights 
for unrestricted research re-use and analyses in any form or by any means 
with acknowledgement of the original source. These permissions are 
granted for free by Elsevier for as long as the COVID-19 resource centre 
remains active. 
 
Virus Research 143 (2009) 147–161
Contents lists available at ScienceDirect
Virus Research
journa l homepage: www.e lsev ier .com/ locate /v i rusres
Review
Influenza virus morphogenesis and budding
Debi P. Nayak a,∗, Rilwan A. Balogun a, Hiroshi Yamada a, Z. Hong Zhou a,b, Subrata Barman a,1
a Department of Microbiology, Immunology and Molecular Genetics, Molecular Biology Institute, Jonsson Comprehensive Cancer Center,
David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
b California NanoSystems Institute (CNSI), University of California at Los Angeles, Los Angeles, CA 90095, USA
a r t i c l e i n f o
Article history:
Available online 27 May 2009
Keywords:
Influenza virus
Morphogenesis
Budding
Assembly
Structure
Morphology
a b s t r a c t
Influenza viruses are enveloped, negative stranded, segmented RNA viruses belonging to Orthomyxoviri-
dae family. Each virion consists of three major sub-viral components, namely (i) a viral envelope decorated
with three transmembrane proteins hemagglutinin (HA), neuraminidase (NA) and M2, (ii) an intermedi-
ate layer of matrix protein (M1), and (iii) an innermost helical viral ribonucleocapsid [vRNP] core formed
by nucleoprotein (NP) and negative strand viral RNA (vRNA). Since complete virus particles are not found
inside the cell, the processes of assembly, morphogenesis, budding and release of progeny virus particles
at the plasma membrane of the infected cells are critically important for the production of infectious
virions and pathogenesis of influenza viruses as well. Morphogenesis and budding require that all virus
components must be brought to the budding site which is the apical plasma membrane in polarized
epithelial cells whether in vitro cultured cells or in vivo infected animals. HA and NA forming the outer
spikes on the viral envelope possess apical sorting signals and use exocytic pathways and lipid rafts for
cell surface transport and apical sorting. NP also has apical determinant(s) and is probably transported
to the apical budding site similarly via lipid rafts and/or through cortical actin microfilaments. M1 binds
the NP and the exposed RNAs of vRNPs, as well as to the cytoplasmic tails (CT) and transmembrane (TM)
domains of HA, NA and M2, and is likely brought to the budding site on the piggy-back of vRNP and
transmembrane proteins.
Budding processes involve bud initiation, bud growth and bud release. The presence of lipid rafts and
assembly of viral components at the budding site can cause asymmetry of lipid bilayers and outward
membrane bending leading to bud initiation and bud growth. Bud release requires fusion of the apposing
viral and cellular membranes and scission of the virus buds from the infected cellular membrane. The
processes involved in bud initiation, bud growth and bud scission/release require involvement both viral
and host components and can affect bud closing and virus release in both positive and negative ways.
Among the viral components, M1, M2 and NA play important roles in bud release and M1, M2 and NA
mutations all affect the morphology of buds and released viruses. Disassembly of host cortical actin
microfilaments at the pinching-off site appears to facilitate bud fission and release. Bud scission is energy
dependent and only a small fraction of virus buds present on the cell surface is released. Discontinuity
of M1 layer underneath the lipid bilayer, absence of outer membrane spikes, absence of lipid rafts in the
lipid bilayer, as well as possible presence of M2 and disassembly of cortical actin microfilaments at the
pinching-off site appear to facilitate bud fission and bud release. We provide our current understanding
of these important processes leading to the production of infectious influenza virus particles.
© 2009 Elsevier B.V. All rights reserved.Contents
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. Introduction
For enveloped viruses, assembly and budding are the penul-
imate and final steps of virus replication, respectively, prior to
elease of infectious progeny virus particles. Lytic viruses such as
nfluenza viruses do not form a stable, long-term host–virus rela-
ionship within the infected host. The very survival of the viruses
hus depends on host to host transmission, which, in turn, depends
n the release of progeny viruses from the infected host. The
nderlying causes of disease syndromes, such as pneumonia and
ronchitis, are basically due to the killing of a large number of
ells of the infected organ(s)/tissue(s) (e.g. the lungs), leading to the
oss of function of the organ/tissue. A number of other factors such
s inflammatory cytokines, invasion of inflammatory white blood
ells, release of fluids from lymphatic and blood vessels further
xacerbate the disease syndrome. Furthermore, humans or animals
re normally infected by influenza virus at a very low multiplication
f infectivity (moi), except in some recent H5 avian virus infection
ases (where it is believed that humans were infected at a very high
ose of virus particles while handling infected chickens). Therefore,
isease progression and host to host transmission of the influenza
irus require efficient release of viral particles from infected host
ells.
Since complete influenza virions are not present inside the
nfected cells and can only be produced by budding from the plasma
embrane, both virus assembly and bud release play critical roles
n infectious virus production, which in turn affects both the sever-
ty of the disease syndrome and transmission of the viruses across
umans and animals. Virulence of influenza viruses is usually mea-
ured by two parameters: (i) Severity of disease production in the
nfected host. (ii) Efficiency of transmission from person to person
r one host to another. Although these two parameters often go
and in hand, it is possible to have highly transmissible virus with
ow virulence and, vice versa, a highly pathogenic virus with low
ransmission.
The goal of this review is to critically analyze the recent
dvances in our understanding of the processes involved in assem-
ly and budding of influenza viruses. The present review primarily
eals with the advances made since the publication of our earlier
eview (Nayak et al., 2004). In addition, readers should read other
eviews on similar subjects published recently (see Chen and Lamb,
008).
. Overview of influenza virus composition, assembly and
udding
Influenza viruses are members of the Orthomyxoviridae fam-
ly, which is a family of negative stranded, segmented, enveloped
NA viruses. Each virion contains helical ribonucleocapsids (also. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
called viral ribonucleoprotein [vRNP]) (Palese and Shaw, 2007).
Influenza virus virions are pleomorphic and are roughly spheroidal
with approximately 100 nm in diameter (Fujiyoshi et al., 1994). The
viral envelope consists of a lipid bilayer containing three trans-
membrane proteins HA (hemagglutinin), NA (neuraminidase), and
M2 (ion channel) on the outside and M1 (matrix protein) under-
neath the membrane. The influenza virus lipid bilayer is a mosaic
structure containing both cholesterol-enriched lipid rafts and non-
raft lipids derived from the host plasma membrane (Scheiffele et
al., 1999; Zhang et al., 2000). HA and NA are anchored in the
lipid raft domain of the viral envelope, whereas M2, though a
cholesterol-binding protein, is not tightly associated with lipid rafts
(Schroeder et al., 2005). HA is the major envelope protein (∼80%)
and forms the trimeric spikes with receptor-binding sites and epi-
topes for neutralizing antibodies. Cleavage of HA into HA1 and
HA2 is critical for virus infectivity. NA is the second most abun-
dant (∼17%) envelope protein and forms the tetrameric spikes. NA
removes the cell surface receptor (sialic acid) and plays a critical
role in the release of progeny virus particles from the cell sur-
face as well as the spread and transmission of virus from host
to host. The third envelope protein M2 is a minor component
(∼16–20 molecules/virion) and functions as an ion channel (see
Lear, 2003; Wu and Voth, 2003). M2 plays a critical role in the early
phase of infection leading to the uncoating and release of the vRNPs
from M1 matrix. The viral core consists of helical vRNPs contain-
ing negative stranded vRNAs and NP along with minor amounts of
the nuclear export protein (NEP) and three polymerase (3P) pro-
teins (PB1, PB2, PA) forming the viral RNA polymerase complex
(3P complex).
Assembly involves bringing the viral components synthesized in
different cellular compartments to the budding site at the plasma
membrane of the host cell. Budding is the process leading to the
formation, growth and release of virus buds. Although influenza
virus assembly and bud release have evolved for the survival of
virus species, both infectious virus particles and non-infectious or
defective virus particles are produced. The process of assembly and
budding is further complicated by the presence of segmented RNA
genome. Each infectious influenza virus packages seven to eight
different RNA/RNP segments (eight in influenza virus A and B and
seven in influenza virus C) and all these individual RNA segments
must be present within the individual virus particle for the progeny
virus to be infectious and transmissible. However, the majority
(≥90%) of released virus particles are non-infectious. Although
some particles may lose their infectivity after their release into
the external environment, defective or incomplete virus particles
can assemble, bud, and are released from the plasma membrane.148 D.P. Nayak et al. / Virus Research 143 (2009) 147–161
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Magnus particles”) attests to the lack of check point(s) against
releasing non-infectious particles (see Nayak et al., 1985). Simi-
larly, recent studies on the production of virus-like particles (VLPs)
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lso support this notion. On the other hand, specific nucleotide
equences of different RNA segments have been shown to favor
ackaging into virions (Liang et al., 2008; Marsh et al., 2007, 2008),
ut not for assembly and bud release. Indeed, virus replication
an be abortive at many stages of the viral life cycle. For exam-
le, in HeLa cells infected with influenza virus, bud formation
ccurred on the cell surface, but failed to be released (Gujuluva
t al., 1994).
Morphogenesis and budding require four steps—assembly of
iral components, bud initiation, bud growth and pinching off from
he plasma membrane. These steps in the budding process are
equential and do not have specific start and stop signals. Bud-
ing is a complex process and involves physical and structural
s well as functional requirements of multiple biological compo-
ents of both virus and host and is among the least understood
rocesses in viral biology. One of the main reasons for the lack of
nderstanding of the budding process is that the biological pro-
esses involving the release of enveloped vesicles from the plasma
embrane of cells into an outside environment is not a common
henomenon exhibited by living cells. Release of neurotransmit-
ers from the nerve endings in synapses and exocytic intracellular
ransport pathway involving vesicle formation, release and fusion
re among the close proximate processes mimicking virus budding.
owever, release of neurotransmitters occurs only in specialized
erve endings in synaptic junctions. Processes of exocytosis and
udding into multivesicular body (MVB) have helped to explain
ome of the steps involved in budding of some viruses such as
IV (Freed and Mouland, 2006). Exocytosis involving release and
usion of vesicles occurs in the intracellular organelles i.e. endo-
lasmic reticulum (ER) and Golgi complexes and ends in fusion of
he vesicles with the plasma membrane leading to either releasing
heir content (e.g. exocrine proteins such as insulin) or transporting
nd anchoring the membrane proteins to its destination e.g. plasma
embrane.
In analyzing the role of viral components in budding, two
ethods are most frequently used: (i) producing VLPs (virus-
ike particles) and (ii) creating mutant viruses by reverse genetics
ither eliminating or mutating specific viral components. Both of
hese processes although useful have limitations in understand-
ng virus budding. For example, in VLP analysis, transfections of
DNA or vRNPs are primarily used and quantification of released
LPs from the transfected cells is assayed. However, in cells trans-
ected with cDNAs or vRNPs, normal regulation of synthesis of
iral components, present in virus-infected cells, is absent. Fur-
hermore, transfection can lead to high or low expression of
pecific viral components in individual cells. This may cause arti-
cial release of VLP depending on concentration of specific viral
omponents, which may not mimic bud release in virus-infected
ells.
In cDNA transfected cells, high concentration of NP in the
ucleus may cause aggregation and nuclear exit without the
equirement of M1 (Carrasco et al., 2004) whereas M1 plays a crit-
cal role in nuclear exit of NP in virus-infected cells. Similarly, high
oncentration of HA in the plasma membrane cDNA transfected
ells may cause bud release (Chen et al., 2007) in the absence of
ther vial components, which does not occur in virus-infected cells.
urthermore, VLP release with limited viral components may indi-
ate only minimal requirements of bud formation and bud release
nd may not reflect the normal budding process in virus-infected
ells. On the other hand, reverse genetics which can create spe-
ific mutant viruses may be the most important and reliable tool
urrently available for analyzing the role of individual viral compo-
ents in budding.
Assay used for the analysis of virus budding is also an impor-
ant consideration. Usually, particle release [either total particle or
laque forming units (PFU)] is used in determining the efficiencych 143 (2009) 147–161 149
of budding. Although total particle release is a quantitatively effec-
tive way in analyzing the budding efficiency, other factors including
synthesis, transport and assembly of viral components may affect
particle release and therefore may not necessarily reflect the effi-
ciency in bud release only. The other method is examining the
morphology of released virus particles and virus buds attached on
the cell membrane by electron microscopy (EM). EM analysis may
provide more direct information about the budding process and
morphogenesis of virus particles. Although fresh field virus isolates
and some laboratory adapted virus such as Udorn (A/Udorn/307/72,
H3N2) may exhibit elongated or even filamentous form, quantita-
tive formation of elongated or filamentous form of mutant WSN or
PR8 virus particles which normally exhibit spheroidal morphology
would indicate a budding defect. If the virus bud cannot be released
(i.e. defective in the process of bud closure), the bud may continue to
grow causing more elongated or even filamentous form. Similarly,
conversion of a filamentous virus to spheroidal form may indi-
cate the removal of a budding block causing efficient virus release.
Although defect in bud release may not always affect virus mor-
phology, alteration in virus morphology is always an indication of
budding defect. Therefore, analysis of virus morphology of either
released virus particles or the buds present on the cell surface may
be considered the gold standard in assessing budding defect and
is the most important tool available at present in studying virus
budding.
3. Virus morphology
Bud closing and bud release may directly affect the size and
shape of released virus particles. Therefore, analysis of the archi-
tecture and morphology of virus particles may provide important
information about the processes of morphogenesis and budding.
Until recently, the morphology of influenza viruses was based
on transmission electron microscopy (TEM) images of negatively
stained viral particles or thin sections of virus-infected cells. In
addition, electron tomography (ET) became available recently to
reconstruct the three-dimensional (3D) structure of viral parti-
cles and thin sections by combining different tilt views of the
same sample (Baumeister, 2002). However, staining and section-
ing procedures often introduce artifacts in the shape, size and
morphology of virus particles during sample processing due to
the use of heavy metal stain at non-physiological pH and sample
drying. Influenza viruses are particularly sensitive to these proce-
dures due to the flexible, pH-sensitive viral envelope. In addition,
the size and shape of virus particles vary with different virus iso-
lates and laboratory strains. Recently, cryo-electron microscopy
(cryoEM) and cryo-electron tomography (cryoET) have been used
to examine the structure of these viruses in their natural state
without fixing and staining. Furthermore, cryoET can be used to
determine the 3D structure of each viral particles by combining
different tilt views of the same viral particles (Baumeister, 2002).
The 3D structures can then be computationally sliced to reveal
the structural arrangement of proteins, nucleic acid and lipids and
their possible interactions in their native state within the virus
particles.
Noda et al. (2006) recently examined influenza WSN (A/WSN/33,
H1N1) virions by ET of both longitudinal and transverse sectioning
of individual virus particles embedded in Epon resin mixture. These
authors found that WSN virions released from MDCK cells were pre-
dominantly spherical in shape. vRNPs inside the virus particle were
suspended from the distal end, and were ∼12 nm in width with
varying lengths up to 130 nm. In transversely sectioned virions, they
found eight electron dense dots arranged as seven in the periphery
with one in the center in many virus particles. They concluded that
each of these dots represents a vRNP and this observation favored
selective over random incorporation of vRNPs in the virus particles.
150 D.P. Nayak et al. / Virus Research 143 (2009) 147–161
Fig. 1. Model virus with HA and NA spikes by cryoET analysis of X31 virus. (a) HA cluster (left); single NA (marked) in a cluster of HA (middle); cluster of mainly NA (right). (b
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Using cryoET reconstruction, Harris et al. (2006) analyzed the
etailed structure of ice-embedded X31 [A/Aichi/2/68(X31), H3N2]
irus particles, which were grown in embryonated chicken eggs.
hey identified five classes of virions with respect to their shape
nd size and arrangement of M1 and vRNP within the virion. The
ost abundant particles (∼80%) were spheroidal with a mean diam-
ter of 120 nm (range 84–170 nm and an average axial ratio 1:2).
he next predominant class (∼14%) had an elongated morphology
ith an average diameter of 100 nm and an axial ratio of 1:4. The
ther three classes of virions represented only a minor fraction of
irions. They noted that the average diameter of elongated parti-
les was shorter than that of the spheroidal particles. These cryoET
tudies also revealed some interesting insight about the structure
nd arrangement of major envelope glycoproteins HA and NA. As
xpected, there were approximately 300 HA (triangular in shape)
nd 40 NA (square in shape) spikes on the surface of each spheroidal
irion. Furthermore, the distribution of HA and NA on the viral sur-
ace were not entirely random, but rather with some local clustering
f NA surrounded by more abundant HA (Fig. 1). Their analysis also
evealed an M1 layer, beneath the lipid bilayer. They observed some
aps in the M1 layer, which coincides with the absence of overly-
ng spikes on the outer surface of the membrane, and the authors
peculated that these gaps may be the point of pinching-off sites
or virus release (see later).
The cryoET analysis by Harris et al. (2006) also showed that RNPs
n the interior of the virus particles is densely packed with similar
imensions as described by Noda et al. (2006). In elongated par-
icles, RNPs formed nearly parallel bundles. However, Harris et al.
2006) could distinguish eight distinct RNP complexes only in a few
articles and observed fewer RNPs in smaller particles. They also
oncluded that the dense inner layer underneath the membrane
presumably M1) had contact with HA and NA tails on the outer
ide and at one or both ends of vRNPs at the inner side. However, no
1 was found to be associated with vRNP inside the virion (Harris
t al., 2006) although studies reported binding of M1 to NP (Noton
t al., 2007) and vRNA exposed on the surface of vRNP (Ye et al.,
999) and M1–vRNP interaction was critical for transport of vRNP
rom the nucleus into cytoplasm and from cytoplasm to the plasma
embrane (the budding site).
We have also analyzed PR8 (A/PR/8/34, H1N1) and WSNA/WSN/33, H1N1) grown in MDCK cells by cryoET. Our analy-
is yielded similar results as that of Harris et al. (2006) except
hat PR8 virus particles were substantially more pleomorphic and
xhibited particles of various shapes and sizes (Fig. 2), whereas
SN, as reported earlier, were relatively uniform and mostlyres of the stem, transmembrane domain and ectodomain are shown schematically.
) Model of distribution of HA (green), NA (gold), and lipid bilayers (blue) in a single
s provided by Drs A. Harris and A.C. Steven. (For interpretation of the references to
spheroidal in size (Fig. 3). PR8 particles ranged from spheroidal
to highly elongated, even filamentous representing irregular shape
and sizes (Fig. 2). PR8 spheroidal particles were also of various
sizes with spike to spike dimension ranging from 73 nm × 57 nm to
288 nm × 267 nm. All particles, including the very small particles
(73 nm × 55 nm), exhibit prominent glycoproteins spikes outside,
and had some electron dense materials corresponding to the vRNP
core inside. However, eight distinct RNP complexes were observed
only in a few particles and the majority contained fewer RNP
complexes as was noted by Harris et al. (2006). In the elongated
particles, vRNPs were parallel to the surface extending essentially
end to end (Fig. 2k). Both triangular (HA) and rectangular (NA)
spikes were observed on the surface as noted previously (Harris
et al., 2006). Reason for extensive heterogeneity observed with PR8
virus is as yet unclear and the role of host (i.e. MDCK vs. chicken
eggs) in virus morphology needs to be examined. Furthermore, it
remains unclear whether the physical shape and morphology of dif-
ferent classes of virions as well as their RNP content also affected the
infectivity of virus particles. It is possible that very small particles
contain less vRNP and therefore may not be infectious. Further anal-
ysis is also needed to determine the relationship of vRNP content
with virus morphology, which in turn may affect infectivity. Unlike
PR8, the majority of WSN particles were spheroidal with spike to
spike dimension ranging from 133 nm × 92 nm to 94 nm × 86 nm
(Fig. 3).
CryoET results by us and Harris et al. (2006) agree with the over-
all vRNP arrangement inside virus particles observed by Noda et al.
(2006) using ET of serially thin-sectioned virions, except that the
majority of particles contained fewer than eight RNP complexes.
Noda et al. (2006) further noted that individual vRNPs were ori-
ented perpendicular to the budding tip and remained suspended
from the distal end of budding virions. According to these authors,
this orientation and arrangement of clusters of vRNP inside viri-
ons supports the model of selected incorporation of vRNPs, which
are recruited, packaged and incorporated as a complete vRNP set
into the virus buds. However, whether the recruitment and pack-
aging of the complete vRNP set occurred after, during, or before the
incorporation of vRNPs into the bud is still an open question since
such intracellular specific vRNP complexes have yet to be demon-
strated. Noda et al. (2006) noted that they did not observe more than
eight vRNP segments inside virions and therefore concluded that a
complex of eight specific vRNP segments were incorporated in the
bud, thus favoring specific over random incorporation of vRNPs.
However, because of the heterogeneity and pleomorphism in both
shape and size of virus particles, RNP content of particles varies
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Fig. 2. Cryo-electron tomography studies of influenza virus A/PR8 strain showing highly pleomorphic virion architecture. (a) A density slice from a 3D cryo-electron tomog-
raphy reconstruction of influenza A virus strain PR8. PR8 virus was grown in MDCK cells at 0.001 moi. The tilt series spanning −70◦ to 70◦ sample tilt were recorded in a
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r e pop
o Harris
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sF20 cryo-electron microscope using the Batch Tomography program (FEI Company)
Winkler and Taylor, 2006). (b–n) Comparison of central slices of viral particles ex
andom. No attempt was made to determine the percentage of each virus form in th
utside. Both HA and NA spikes, as identified based on morphology as described inreatly and each virus particle may not contain a full set of eight
RNPs. Therefore, incorporation of a complete set of vRNP complex
ay not occur in each virus particle and incorporation of specific
RNP complex may not significantly affect budding and bud release
ig. 3. CryoET reconstruction of influenza virus A/WSN strain showing more homogeneo
DCK cells at 0.05 moi. (a) A density slice from a 3D cryo-electron tomography reconstru
s compared to PR8 virus. (b–e) Comparison of central slices of viral particles extracted fro
ade to determine the percentage of each virus form in the population. Each virus particl
pikes, as identified based on morphology as described in Harris et al. (2006), were visiblreconstructed using the Inspect3D (FEI Company) and refined by Protomo program
from different cryo-electron tomograms. Different virus particles were picked at
ulation. Each virus particle contained electron dense spots (RNP) inside, and spikes
et al. (2006), were visible on the outer membrane. Scale bar 50 nm.although vRNP incorporation may facilitate bud formation and bud
release. Also, further analysis is required to determine whether
larger and elongated particles contain more than eight vRNP
segments.
us architecture as compared to PR8. The WSN strain virus particles were grown in
ction of influenza A strain WSN. Virus morphology was relatively less pleomorphic
m the tomogram. Different virus particles were picked at random. No attempt was
e contained electron dense spots (RNP) inside, and spikes outside. Both HA and NA
e on the outer membrane. Bar scale 50 nm.
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. Transport and assembly of viral components and
election of budding site
Bud formation and bud release require assembly of viral compo-
ents, which can occur either during transport or during budding
t the budding site. During the assembly process, viral components,
ither individually or in the form of complexes, are brought to the
udding site to form a higher order of complex which may facilitate
ud initiation and/or bud completion. With the majority of viruses
ither enveloped or non-enveloped, assembly implies the forma-
ion of complete capsid, either helical or icosahedral including
ncorporation of the genome in the capsid. Furthermore, with the
ajority of enveloped viruses, capsid formation is a requirement for
ud formation and bud release as is shown for retrovirus like human
mmunodeficiency virus (HIV) (Ganser-Pornillos et al., 2008), and
lpha viruses like Semliki forest viruses (SFV) (Garoff et al., 1994).
ven for enveloped viruses possessing helical nucleocapsids like
SV, formation of nucleocapsid is critical for bud formation and bud
elease. In fact, the size of the nucleocapsid which is determined by
he size of vRNA, determines the size and shape of the released VSV
articles. For example, smaller DI (defective interfering) virus par-
icles contain shorter vRNA/RNP (nucleocapsid) compared to the
ullet shaped elongated virus particles of wild-type viruses con-
aining the complete and longer vRNA/RNP (Pattnaik and Wertz,
991). Therefore, with these viruses, capsid assembly is a critical
equirement for virus budding. However, requirements of capsid
ssembly and budding are much more complex for influenza viruses
or a number of reasons. Firstly, budding may occur in the absence
f vRNPs and/or with incomplete vRNPs. Furthermore, the viral
enome consists of multiple segments of vRNAs/vRNPs. Therefore,
udding of infectious virus particles requires that each segment of
RNPs must be incorporated into the bud. Secondly, all the compo-
ents of the virus namely, envelope containing the transmembrane
rotein (HA, NA, and M2) as well as M1 and vRNPs must be brought
ither individually or as a complex to the budding site for bud ini-
iation, bud growth, and finally, release of infectious virus buds.
lthough much is known about the mechanism and the process
nvolved in transporting individual viral components to the bud-
ing site, less is known about where such sub-viral complexes are
ormed and how they are brought to the budding site. Finally, lit-
le is known about the requirements of these complexes or the
omponents for bud initiation, bud growth and bud release.
Although assembly and budding are discussed separately, it is
n fact a continuous process, one leading to the other as men-
ioned earlier. Furthermore, it is unclear if there are check points
r switches in this continuous process i.e. whether the completion
f a previous step is required for initiation of the succeeding step.
ormally, one would expect some regulation for the progression of
process involving different steps but such specific stop and start
witches are as yet unknown in influenza assembly and budding.
oreover, it is unknown if there are different requirements for the
udding process of infectious vs. non-infectious particles leading
o favoring one over the other. Also, since influenza viruses bud
rom the plasma membrane into outside environment, and since
omplete virus particles are not found inside the cell, assembly
f virus components into virus particle must occur at the plasma
embrane, the budding site.
As noted earlier, influenza virus particles contain three sub-viral
omponents namely, (a) viral envelope which consists of a lipid
ilayer and viral transmembrane proteins (HA, NA, and M2). Lipids
re selectively derived from host. (b) M1 protein underneath the
ipid bilayer, which forms the bridge between the envelope, and
iral core. (c) Virus core (viral nucleocapsid) which consists of vRNP
minus stranded vRNA and NP) and minor amounts of NEP, and
P (polymerase) protein complex. Each nucleocapsid (vRNP) is a
upercoiled ribbon structure with a terminal loop where the vRNAch 143 (2009) 147–161
is coiled around NP monomer to form a hairpin structure and vRNA
is exposed on the outer surface of NP (Elton et al., 2006). Therefore,
assembly involves the formation of these sub-viral complexes and
their transport to the budding site, the apical domain of the plasma
membrane in polarized epithelial cells whether in cultured cells in
laboratory or respiratory epithelium of infected animals.
4.1. Transport and assembly of viral components
Transport of the transmembrane envelope proteins (HA, NA, and
M2) has been studied extensively (see Nayak et al., 2004). As men-
tioned earlier, the viral membrane is a mosaic containing both raft-
and non-raft-associated lipids where both HA and NA are inserted
in the raft domains and M2 in the non-raft lipid domains. These
transmembrane proteins use cellular exocytic transport pathway
for apical transport and possess the determinants for both lipid raft
association and apical transport in their transmembrane domain
(TMD). Lipid raft association of TMD is responsible for apical trans-
port of both HA and NA (Lin et al., 1998; Barman and Nayak, 2000).
On the other hand, how M1 and RNP are transported to the bud-
ding site (i.e. apical plasma membrane) is not fully understood. M1
is not known to possess any apical determinant but possesses deter-
minants for lipid binding, RNA/RNP/NP binding (Baudin et al., 2001;
Noton et al., 2007; Watanabe et al., 1996; Ye et al., 1999), and associ-
ating with HA and NA tails (Ali et al., 2000). Therefore, it is likely that
some M1 can be transported to the budding site of apical plasma
membrane on the piggy-back of HA and NA.
Since RNP is synthesized in the nucleus it must be exported
from the nucleus into cytoplasm before being transported to the
apical plasma membrane. M1, a small protein possessing nuclear
localization signal (NLS) can enter the nucleus, interact with vRNP
as well as with NEP forming the daisy-chain complex of (Crm1
and RanGTP)–NEP–M1–RNP, and mediate nuclear export of v-RNP
(Akarsu et al., 2003; Whittaker and Digard, 2006). M1–RNP com-
plex has been demonstrated both in infected cells and in virions
(Zhirnov, 1992; Ye et al., 1999). Interaction of M1 with RNP pre-
venting transcription is critically required for exit of vRNPs into
cytoplasm and incorporation into virions since only transcription-
ally inactive vRNP with the polymerase complex present only at the
end of vRNP are found in virus particles (Murti et al., 1988). Recent
studies suggest that NP/RNP may possess an as yet undefined deter-
minant for apical transport (Carrasco et al., 2004). NP/RNP exits
nucleus from its apical side and is transported to the apical plasma
membrane of polarized MDCK cells (Fig. 4). NP/RNP was also shown
to interact with actin microfilaments (Avalos et al., 1997) and asso-
ciate with lipid rafts (Carrasco et al., 2004). Therefore, it is likely that
RNP along with the associated M1 can be directed to the apical bud-
ding site via its association with cortical actin microfilaments and
lipid rafts. However, neither the apical determinant(s) of NP/RNP
nor the cellular machinery involved in its apical transport has been
identified.
Finally, since the genome of influenza virus is segmented, mul-
tiple vRNA/vRNP segments (eight separate segments for influenza
type A and B, seven segments for influenza type C viruses) must
be incorporated into each infectious virus particle (see later). How-
ever, as noted earlier, although packaging of different RNP segments
in the virus bud is critically important for infectivity of virus
particle, assembly or incorporation of genomic segments do not
appear to play an important role in the budding of virions. On
the other hand, M1 plays a critical role in the assembly process,
as it interacts with multiple components and brings viral com-
ponents together. M2 interacts with M1 via cytoplasmic tail and
thereby plays an important role in virus assembly, genome pack-
aging and budding (Iwatsuki-Horimoto et al., 2006; McCown and
Pekosz, 2005, 2006). The following complexes of viral components
have been identified either in the infected cells or in virions and
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red, with propidium iodide) and examined by confocal microscopy. Single optical
hown for merged fluorescence. (For interpretation of the references to color in this
re likely to play major role in virus assembly and some also
n budding process: HA–HA (trimer), HA–M1, NA–NA (tetramer),
A–M1, M1–M1 (multimer), M1–M2, M1–NP, M1–RNA, M1–RNP,
1–RNP–NEP, NP–RNA, PB1–PB2–PA (3P), 3P–RNP, 3P–RNP–M1,
B1/PB2–NP. However, complexes involving vRNP–vRNP interac-
ion have not been physically demonstrated, although inferred from
iological, mutational and morphological analysis.
.2. Selection of the budding site
Influenza viruses bud specifically from the apical domain of the
lasma membrane of infected polarized cells, regardless in cultured
ells or in respiratory epithelium of infected animals. However,
hat determines the selection of the apical budding site is not clear.
or majority of the viruses, viral glycoproteins are thought to be
mportant in the selection of the budding site since virus glyco-
roteins, even when expressed alone in the absence of other viral
omponents, predominantly accumulate at the site of virus bud-
ing. Viruses such as hepatitis B virus, bunyaviruses, coronaviruses,
nd others that bud from the internal sub-cellular organelles, pos-
ess intrinsic determinants for the same sub-cellular localization
s the site of virus budding (for review, see Hobman, 1993). On
he other hand, for viruses budding from the plasma membrane,
he viral glycoproteins possess either apical or basolateral sorting
ignals and are directed to the specific site where virus assembly
nd budding occur in polarized epithelial cells. The surface glyco-
roteins of viruses such as influenza virus, parainfluenza virus, or
espiratory syncitial viruses (RSV) budding from the apical plasma
embrane, possess apical sorting signal(s) and predominantly
ccumulate at the apical plasma membrane in polarized epithelial
ells. Conversely, for viruses that are released from the basolat-
ral membrane, their surface glycoproteins, possessing basolateral
orting signal, are transported basolaterally in polarized epithe-
ial cells even when these proteins are expressed alone. Vesicular
tomatitis virus (VSV), Semliki forest virus (SFV), vaccinia virus,
nd certain retroviruses including human immunodeficiency virus
ype 1 (HIV-1) exhibit basolateral budding. Furthermore, in differ-
nt cells and tissues where some viruses bud from the opposite
omains of the plasma membrane, their glycoproteins are dis-
ributed accordingly. For example, Semliki forest viruses (SFV) buds
pically from FRT cells but basolaterally from CaCo-2 cells; similarly,
n the absence of any other viral protein, p62/E2, the envelope gly-
oproteins of SFV, are targeted apically in FRT cells but basolaterally
n CaCo-2 cells (Zurzolo et al., 1992). However, there are examples of
olarized virus budding occurring independently of the polarized
nvelope viral glycoprotein sorting. For example, although measles
irus glycoproteins H and F are transported in a random fashionP (delHA, del-NA, and del-M2-CT-TMD) infected (A) or wt virus-infected (B) MDCK
nin and triple-stained for NP (green), tight junction protein ZO-1 (blue) and DNA
n in the xy plane (A, upper, top/apical surface) and xz planes (A, lower and B) are
e legend, the reader is referred to the web version of the article.)
or to basolateral membrane, respectively, virus budding occurred
predominantly from the apical surface of polarized MDCK cells
(Maisner et al., 1998). Similarly, the spike protein of coronavirus
is not involved in the polarized budding of this virus (Rossen et al.,
1998). Moreover, Marburg virus buds predominantly from the baso-
lateral surface, while its glycoprotein is transported to the apical
surface (Sanger et al., 2001).
Influenza virus, which assembles and buds from the apical
plasma membrane in polarized epithelial cells, has been used
extensively as a model for studying protein targeting. The three
envelope glycoproteins, HA, NA and M2 proteins are transported
to the apical plasma membrane in virus-infected cell, as well as in
cDNA transfected polarized epithelial cells when expressed alone.
Since HA is the major glycoprotein on influenza virus envelope, its
role on the apical budding of virus was determined. Using a trans-
fectant influenza virus (HATyr) containing basolaterally targeted
HA (Cys543 → Tyr543), it was shown that the basolateral targeting
of HA did not significantly alter the apical budding of influenza virus
(Barman et al., 2003; Mora et al., 2002). Over 99% of the virus par-
ticles containing the HAtyr were released from the apical side even
though the majority of HAtyr was directed to the basolateral side.
However, when virus budding was examined by thin section trans-
mission electron microcopy one significant difference was observed
in HAtyr-infected cells. In the lateral intercellular space of HAtyr-
infected cells, the presence of empty virus-like structures (Barman
et al., 2003) with the same size diameter as the virus particles
at apical surface was often observed. These virus-like structures
were not seen in wt WSN-infected cells and found only in HAtyr-
infected cells (Barman et al., 2003). Likely, these particles represent
abortive virus buds containing HA and M1 but not vRNP, suggest-
ing that vRNP may play a role in polarized budding of influenza
virus. Later on Carrasco et al. (2004) demonstrated that in later
stages of influenza virus-infected cells, NP/vRNP localized at the
apical but not basolateral membranes in both polarized (MDCK)
and non-polarized (BHK and 293T) cells although HA was present
on apical membrane of MDCK cells and on both apical and lat-
eral membranes of 293T cells. These findings suggested that apical
targeting of NP/vRNP was independent of HA. Furthermore, api-
cal targeting of NP was also shown to be independent of M1 and
NEP which did not accumulate to the apical membrane (Carrasco et
al., 2004). Also, when expressed alone in BHK cells (non-polarized
fibroblast) using cDNA transfection, NP was also localized specifi-
cally to the apical side. It was further shown that apical distribution
of NP correlated with its association to detergent resistant lipid rafts
by flotation assay of membranes from virus-infected and plasmid-
transfected cells. However, in these experiments, apical localization
of NP in transfected polarized epithelial (such as MDCK) cells was
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ot demonstrated.We have examined the localization of NP/vRNP
n VLP-infected polarized MDCK cells which lack the expression of
iral envelope proteins. Accordingly, infectious VLPs were produced
sing methods similar to the virus rescue protocol using cDNA
ransfection of 293T cells. Stop codons were introduced after ATG of
A and NA and after 26 aa position of M2 cDNAs (to allow expres-
ion of M1 but not M2) in pol I and II cDNA plasmids and HA, NA, and
2 were expressed in cDNA transfected cells using protein expres-
ion plasmids. VLPs obtained from this system were used to infect
olarized MDCK cells. In VLP-infected polarized MDCK cells lacking
he expression of HA and NA and M2 proteins except the N-terminus
6 aa of M2 (without the cytoplasmic tail and transmembrane
omain), NP was expressed efficiently and found to accumulate
t the apical plasma membrane, similar to that observed in wt
irus-infected cells (Fig. 4). As expected from previous observa-
ion (Elton et al., 2005), exit of NP was observed to occur through
pical side of the nucleus in wild-type (wt) virus-infected (Fig. 4,
anel B) as well as in VLP-infected (not shown) polarized MDCK
ells. Taken together these results demonstrate that NP/vRNP can
e transported independently to the apical plasma membrane of
olarized epithelial cells in the absence of transmembrane viral
roteins. Therefore, transmembrane proteins alone do not deter-
ine the site of virus budding and NP also plays an important
ole in apical budding of influenza A viruses. Determinants of NP
nd cellular machinery involved in its apical transport are yet to
e determined. Cortical actin microfilaments as well as lipid rafts
ay aid in apical transport since NP binds to both of these host
omponents.
. Role of virus components in budding
.1. Role of structural proteins
A number of viral components are involved in the assembly
nd budding processes. However, some may be involved in dif-
erent stages of bud initiation, bud growth or bud release while
thers may be involved in multiple steps of the budding process
ncluding bud release. Again, the assessment of their involvement
as been analyzed quantitatively by particle or pfu release and/or
xamining the morphology of the virus buds on the cell surface
r released particles. It appears that all three transmembrane pro-
eins (HA, NA, and M2) are involved in the assembly and budding
rocesses. However, direct involvement of HA alone in the bud-
ing process appears to be controversial. VLP assays by transfection
n baculovirus expression system in Sf9 insect cells (Latham and
alarza, 2001) and T7 expression system in COS-1 cells (Gomez-
uertas et al., 2000) indicated that HA alone in the absence of M1
annot cause VLP production. On the other hand, using VLP assay
n mammalian cells (293T and COS-1 cells) Chen et al. (2007) con-
luded that HA but not M1 was critical for budding and bud release.
owever, using mutant viruses produced by reverse genetics, it was
eported that HA tail mutation alone did not affect virus budding
ncluding the shape and size of released particles whereas specific
A mutants in the CT affected virus morphology, generating elon-
ated virus buds and highly irregular particle shape. Furthermore,
utant viruses lacking tails of both HA and NA (HAt-/NAt-) caused
he formation of bizarre virus morphology (Jin et al., 1997). Barman
t al. (2004) showed that some NA CT substitution and NA TMD
eplacement mutants produced elongated particles clearly indicat-
ng a defect in the pinching-off process of virus buds caused by
A mutants. Similarly, some M1 mutants produced elongated virus
articles indicating the involvement of M1 in the last step of bud
elease (Burleigh et al., 2005; Nayak et al., 2004).
Complete or partial deletion of WSN M2 tail were shown to
ause attenuation of virus growth, produce elongated, even fila-
entous particles in some mutants, indicating an important role ofch 143 (2009) 147–161
M2 tail in viral assembly and morphogenesis (Iwatsuki-Horimoto
et al., 2006). Mutations in Udorn M2 tail were also shown to
affect particle release in VLP assay by cDNA transfection suggesting
their role in budding (Chen et al., 2008). These M2 mutants were
extremely defective in multi-cycle virus growth, and unlike the wt
M2, they were defective in M1–M2 interaction as determined by
co-immunoprecipitation. However, since the morphology of virus
buds on the cell surface and released VLPs were not examined quan-
titatively by EM, it is unclear if these M2 mutants affected only bud
release and bud morphology but also the virus assembly and bud
initiation processes.
Furthermore as indicated earlier, budding and release of VLPs
using cDNA transfection may only indicate the minimum require-
ments for budding and bud release and may not mimic the budding
process in virus-infected cells since the regulation and control
involved in synthesis and assembly of different viral components
in virus-infected cells may not be present in cells transfected by
cDNAs. Also, VLP production may be affected by over-expression
or under-expression of specific viral components in individual cells
depending on the permissiveness of specific cells for cDNA transfec-
tion and entry of the copy number of individual cDNAs. For example,
although equimolar concentrations of different cDNAs are used in
transfection, some cells may be transfected with higher copy num-
ber of a specific cDNA. Increased expression of specific protein and
under expression of other proteins may cause an artificial concen-
tration effect of a specific protein on bud formation and bud release
and therefore, may not reflect the role of a specific protein in bud
formation and bud release from virus-infected cells.
M1 is clearly an important protein involved not only in virus
assembly but also in virus budding and bud release. As noted ear-
lier, M1 affects virus assembly by interacting with transmembrane
proteins (HA, NA, and M2) on the outer side and core vRNP on the
inner side as well as by bringing and concentrating these viral com-
ponents to the budding site. Furthermore, M1 is present underneath
the lipid bilayer and interacts with each other causing asymme-
try in the lipid bilayer and thereby, facilitating membrane bending
required for bud initiation. In addition, M1 appears to be a criti-
cal component in the final step in bud closing, causing bud release.
Bourmakina and García-Sastre (2005) suggested that a threshold
level of M1 was required for bud release since low levels of M1
and M2 reduced virus release. However, the virus morphology or
viral protein composition was not affected by the low levels of M1
and M2. M1 was found to be critical for maintaining the filamentous
morphology of A/Udorn/72 virus particles (Bourmakina and García-
Sastre, 2003) and a single mutation in M1 (1A variant) caused
transformation from filamentous to spherical particle (Roberts et
al., 1998). The role of M1 in virus morphology and virus release
is clearly evident also from the budding defect causing forma-
tion of elongated buds and released particles by some M1 mutants
(Burleigh et al., 2005; Nayak et al., 2004). In addition, an influenza C
M1 mutant rMG96A (M1A24T) appears to affect virus morphology
by modulating its membrane affinity (Muraki et al., 2007). These
studies indicate that M1 plays an important role in many aspects of
virus budding including bud closing. Other structural components
of influenza virus particles including NEP and polymerase proteins
although are critical in many aspects of influenza virus replication
appear not be involved in the assembly or the budding process.
5.2. Role of the eight vRNP segments in virus budding
It appears that incorporation of vRNP segments in the virus par-
ticles are not absolutely required for budding and bud release since
expression of structural proteins (HA, NA, M1, and M2) can release
VLP (Gomez-Puertas et al., 2000; Latham and Galarza, 2001; Chen
et al., 2007). However, incorporation of all eight (seven for influenza
C) vRNA segments are required for the formation of infectious virus
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articles and M1 and NP play important roles for the incorpora-
ion of vRNPs (Neumann et al., 2000; Chen et al., 2007; Li et al.,
009) in virus particles. How these multiple vRNA/vRNP segments
re incorporated into virus particles still remains unclear.
Two models have been proposed for the incorporation of eight
RNA/vRNP segments into virions: “random packaging” and “spe-
ific packaging”. The “random packaging” model predicts the
resence of common structural elements in all vRNPs causing them
o be incorporated randomly into virions and therefore incorpo-
ation of vRNPs will be concentration dependent. Support for this
odel comes from the observation that influenza A virions can pos-
ess more than eight vRNPs (9–11 vRNAs per virion) (Bancroft and
arslow, 2002; Enami et al., 1991) and at most 1 in 10 or more virus
articles are infectious. On the other hand, the “specific packag-
ng” model assumes specific structural features are present in each
RNA/vRNP segment, enabling them to be selectively incorporated
nto virions. Evidence for this model is deduced mainly from the
nding that the various vRNAs are equimolar within viral particles
ven though their concentrations in infected cells may vary (Smith
nd Hay, 1982). The selective packaging model has been favored by
he earlier studies demonstrating that the small DI vRNAs can com-
etitively inhibit the packaging of their normal counterparts but
ot that of other vRNAs (Duhaut and McCauley, 1996; Nakajima et
l., 1979; Nayak et al., 1985, 1989; Odagiri and Tobita, 1990). Recent
tudies have demonstrated the presence of segment-specific pack-
ging signal(s) in 3′ and 5′ UTR as well as adjacent coding regions
varying with specific RNA segment as well as with 3′ or 5′ends).
pecific packaging signals have been found for all eight RNA seg-
ents (Watanabe et al., 2003; Fujii et al., 2003, 2005; Liang et al.,
005; Muramoto et al., 2006; Ozawa et al., 2007; Li et al., 2009)
nd incorporation of some specific RNA segments is critical for the
ncorporation of other RNA segments (Muramoto et al., 2006; Marsh
t al., 2008).
ET studies of serially sectioned influenza A virus particles
howing that the RNPs of influenza A virus are organized in a
istinct pattern (seven segments of different lengths surround-
ng a central segment) also argues against random incorporation
f RNPs into virions, and supports the “specific packaging” model
Noda et al., 2006). Such a model would require that specific
RNA–vRNA interaction among the vRNP segments in trans would
orm multi-segmental vRNP macromolecules for incorporation into
irus particles and that large vRNP complexes containing eight
nique vRNPs in trans are stable. However, such intracytoplasmic
ulti RNA/RNP complexes have not yet been demonstrated. More
mportantly, bud closure and virus release should not occur until
uch vRNP complexes containing eight specific vRNP segments are
ormed and incorporated in the bud. In support of this model, Fujii et
l., 2003 demonstrated that the efficiency of infectious virion pro-
uction correlated with the number of different vRNA segments.
hey observed that the higher the number of different vRNA seg-
ents the higher was the efficiency of virion production. Recently,
pecific nucleotide residues in 3′ and 5′ end (coding and non-
oding) of PB1, PB2, and PA (Liang et al., 2008; Marsh et al., 2008) as
ell as in HA (Marsh et al., 2007), have been further shown to play
ritical role for packaging of specific vRNA segment into progeny
irions. The major weakness of this model is that bud closure and
irus release do not appear to depend on the incorporation of eight
pecific RNA segments and particles with fewer RNP segments are
ound (see Section 3). However, it is possible that segment-specific
omplex formation and incorporation of viral RNA may occur but
ay not affect bud closing and bud release.. Role of host components in budding
It is well established that budding of enveloped viruses requires
he function of both viral and host components. As mentioned ear-ch 143 (2009) 147–161 155
lier, budding and bud release require assembly of viral components
either prior to or during the budding process which includes bud
initiation in the form of membrane bending, bud growth, i.e. devel-
opment of fully mature buds and finally, bud scission leading to bud
release from the plasma membrane into the outer environment. It
is unlikely that accumulation and aggregation of viral components
alone in the lipid raft microdomains of the plasma membrane will
be sufficient to complete these complex multiple steps from bud
initiation to bud release (Reynwar et al., 2007). The role of host
components in the assembly processes including transport of viral
components to the specific membrane sites, interaction leading to
accumulation of different viral components at the budding site,
and initiation of membrane bending is well established (Nayak et
al., 2004). However, the requirements of specific host components
in bud maturation and bud release of influenza viruses are poorly
understood.
Furthermore, different steps of the budding process may be
either positively or negatively regulated i.e. some host components
may facilitate specific steps of the budding process while others
may regulate or inhibit one or more steps in budding. Therefore,
these inhibitory components are to be removed from the budding
site whereas others which facilitate budding are to be brought to
the budding site. Furthermore, the same host component may aid
in some step(s) of budding but may interfere with other steps. For
example, lipid rafts are clearly important in transporting and con-
centrating viral components such as HA and NA to the apical domain
of the plasma membrane and are also involved in transporting RNP
and M1 to the budding site and facilitating their interaction dur-
ing virus assembly. Lipid rafts also may cause membrane bending
and bud initiation. However, lipid rafts may regulate and inter-
fere with bud closing and bud release, and removal of lipid rafts
may facilitate bud release (Barman and Nayak, 2007), the final
step in the budding process. Similarly, cortical actin microfilaments
may aid in stabilizing multiple vRNPs into complexes and bringing
the vRNP/M1 complex to the budding site and also promote bud
growth and maturation by pushing the vRNP complex into the bud.
But actin microfilaments may interfere in last step of bud fission.
Disruption of actin microfilaments helps in bud release in HeLa
(Gujuluva et al., 1994) and MDCK (Roberts and Compans, 1998;
Simpson-Holley et al., 2002) cells. Furthermore, microfilament-
disrupting agents caused selective inhibition of filament formation
and resulted in the preferential assembly and release of spherical
particles (Roberts and Compans, 1998; Simpson-Holley et al., 2002).
Influenza virus budding also is an active energy-dependent process
requiring ATP (see Nayak et al., 2004). Recently, proteomic analy-
sis of purified influenza virus particles has shown the presence of
36 host encoded proteins in virions. Among these, at least seven
host proteins including B-actin, annexin A5, tubulin, cyclophilin A
and A2, colifilin, and GAPDH were present in virus particles after
subtilisin protease treatment whereas CD9 and CD59 were absent
in protease-treated virions suggesting the incorporation of some
host proteins inside virus particles (Shaw et al., 2008). It is possible
that some of these host proteins may also have role in bud clos-
ing. As mentioned earlier, B-actin interacts with vRNP/NP (Avalos
et al., 1997) and affects virus budding and virus release (Roberts
and Compans, 1998; Simpson-Holley et al., 2002).
For a number of enveloped viruses, the role of specific host com-
ponents in bud release has been demonstrated. The role of VPS
(vesicular protein sorting) components in bud release of HIV and
other enveloped viruses has been investigated extensively. Bud scis-
sion of these viruses depends on the interaction of their L domain(s)
with the components(s) of VPS pathways involved in giving rise to
multivesicular bodies (MVB). Tsg101 and AIP1/Alix, the components
of ESCRT (endosomal sorting complex required for transport) inter-
act with L domains and require the function of AAA-ATPase of Vps4
for bud release of HIV (see Fujii et al., 2007; Demirov and Freed,
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004). However, influenza virus proteins do not contain any iden-
ifiable L domain(s) and its budding is not affected by dominant
egative Vps4 (Chen et al., 2007) or by proteasome inhibitors (Hui
nd Nayak, 2001; Khor et al., 2003). Recently, budding of RSV was
hown to be affected by dominant negative mutant (FIP2deltaC2)
f Rab11 family interacting protein2 (FIP2) producing elongated fil-
ments (Utley et al., 2008). RSV does not have an identifiable L
omain and is not affected by dominant negative Vps4 or by protea-
ome inhibitors (Utley et al., 2008). However, specific RSV protein
omains interacting with FIP2 protein has not yet been identified.
By mutational analysis using reverse genetics, mutants of three
nfluenza proteins NA, M2 and M1 have been shown to interfere
ndividually in the final step in bud closure producing elongated
nd tethered virus particles (Nayak et al., 2004; Barman et al.,
004; Burleigh et al., 2005; Bourmakina and García-Sastre, 2003,
005; Roberts et al., 1998; Chen et al., 2008). However, cause of the
udding defect by these mutant influenza viruses including pos-
ible interaction with host components is yet to be determined.
nvolvement of transmembrane proteins affecting virus morpho-
enesis and bud release is rather uncommon. However, NS3 and
S3A which are non-structural glycosylated proteins present at
he surface of BTV-infected cells affect virus budding (Hyatt et al.,
993). Also, F13L envelope protein of vaccinia virus (Honeychurch
t al., 2007) has been shown to possess L like domain and use Vps
athways of ESCRT complex.
Lipid rafts are lipid microdomains enriched in sphingolipids and
holesterol. As mentioned above, lipid rafts have been shown to play
ritical roles in many aspects of the virus life cycle, including viral
ntry and fusion, viral protein transport and targeting, and finally
iral assembly and budding process (see Nayak and Barman, 2002;
ayak and Hui, 2004; Nayak et al., 2004; Ono and Freed, 2005;
chmitt and Lamb, 2004, 2005). They contain lipids in liquid order
lo) phase and are relatively resistant to nonionic detergent at a low
emperature (see Brown and London, 1998; Simons and Toomre,
000). Among the three influenza viral envelope proteins, HA and
A, but not M2, use lipid rafts as a platform for apical transport and
emain associated with lipid raft microdomains present on cellular
nd viral membranes (Nayak and Hui, 2004; Nayak et al., 2004).
owever, Schroeder et al. (2005) reported that M2 is a cholesterol-
inding protein and proposed that M2 may play a critical role in
irus budding. Mutational analysis of HA and NA transmembrane
omain (TMD) and cytoplasmic tail (CT) showed that strong raft
ssociation is not obligatory for their apical transport and virus
ssembly (Barman and Nayak, 2000; Barman et al., 2004; Takeda
t al., 2003). Lipid rafts have been also proposed to be involved in
ransporting NP/vRNP to the apical side of polarized epithelial cells
Carrasco et al., 2004). More recently, it was shown that membrane
ccumulation of hemagglutinin and its tight association with lipid
aft domains triggered activation of the MAPK cascade via protein
inase C alpha activation and induced RNP export from nucleus into
ytoplasm (Marjuki et al., 2006). Authors hypothesized the pres-
nce of an auto-regulative mechanism which coordinates timing of
NP export to a point when all viral components are ready for virus
udding at the plasma membrane (Marjuki et al., 2006).
In the envelope of released virions, both HA and NA remain
aft associated, whereas M2 does not associate with lipid rafts.
herefore, the influenza viral envelope is not a homogeneous
ipid membrane but a mosaic mixture of both raft-associated and
on-raft-associated lipid microdomains even though the major-
ty of lipids present in the viral envelope are in the highly
rdered lo phase, and the influenza virus envelope is enrichedn cholesterol-dependent detergent-insoluble lipids (Zhang et al.,
000; Scheiffele et al., 1999). Furthermore, protein–protein inter-
ctions may facilitate bringing non-raft-associated proteins to lipid
aft microdomains. For example, interactions of influenza virus M1
ith HA and NA bring M1, a non-raft-associated protein, into lipidch 143 (2009) 147–161
rafts (Ali et al., 2000). Using recombinant influenza A virus contain-
ing mutant HA that does not associate with lipid rafts, Takeda et
al. (2003) observed reduced budding in cells infected with mutant
virus compared to that seen with wild-type virus. These observa-
tions suggest that influenza viruses use lipid rafts as their budding
platform. However, little is known about the role of lipid rafts in
the budding process, specifically in bud release. Cholesterol is a
known critical structural component of lipid rafts and depletion
of cholesterol leads to disorganization of lipid raft microdomains
and dissociation of proteins bound to the lipid rafts (Hanada et
al., 1995; Hannan and Edidin, 1996; Zhang et al., 2000; Scheiffele
et al., 1999). Recently, it was shown that depletion of cholesterol
from virus-infected cells by MCD treatment for a short time at
the late phase of infection facilitated bud completion and increased
virus particle release (Barman and Nayak, 2007). MCD is a strictly
surface-acting agent and can selectively and rapidly remove choles-
terol from the plasma membrane in preference to other membrane
lipids and has been widely used in studying the effects of cholesterol
depletion and lipid raft disassembly (Gosselin-Grenet et al., 2006;
Ono and Freed, 2001). Therefore, short MCD treatment at the late
phase of infection was done to avoid the effect of lipid raft disrup-
tion on protein transport (Carrasco et al., 2004; Keller and Simons,
1998; Prydz and Simons, 2001) and virus assembly (Leser and Lamb,
2005; Scheiffele et al., 1999; Takeda et al., 2003; Zhang et al., 2000).
The results show that depletion of cholesterol from virus-infected
cells by MCD treatment for a short time facilitated bud comple-
tion and increased virus particle release. Increased release of virus
particles was quantified by three independent assays: (i) higher
infectious virus titer as determined by PFU assay, (ii) increased par-
ticle release as determined by protein analysis, and (iii) increased
number of virus particles as determined by negative-stain EM.
Increased release of virus particles correlated with lipid raft dis-
ruption as measured by the decreased TX-100 insolubility of cell
surface HA and NA. Finally, and most importantly, the presence of
exogenous cholesterol was shown to reverse the effect of MCD.
Exogenous cholesterol increased the TX-100 insolubility of HA and
NA, reduced the release of virus particles, and produced deformed,
elongated particles (Fig. 5). Recently, Wang et al. (2007) reported
that the interferon-inducible protein viperin inhibited influenza
virus release, more specifically the bud pinching-off process (Wang
et al., 2007). Authors have further stated that the expression of
viperin disrupted lipid rafts and concluded that viperin induced dis-
ruption of lipid rafts was responsible for reduced virus release. Their
conclusion contradicts the observation stated above that disruption
of lipid raft by cholesterol depletion enhances virus particle release
and that higher integrity of lipid raft by exogenous cholesterol
caused reduction of particle release (Barman and Nayak, 2007). One
possible explanation of these conflicting results may be the defini-
tion of lipid raft disruption and the assay used in determining lipid
raft disruption by Wang et al. (2007). In standard assays, insolubil-
ity of the cell surface HA by 1% TX-100 treatment at 4 ◦C is used for
comparing and defining the integrity and disruption of lipid rafts.
However, Wang et al. (2007) used very low concentration (0.1%) TX-
100 solubility followed by 1% TX-100 treatment of the total HA, not
just cell surface HA in viperin expressed and mock treated cells for
assaying lipid raft disruption. Furthermore in their analysis, imma-
ture (non-lipid-raft-associated) and mature (lipid raft-associated)
forms of HA were not separated or quantified. It is therefore likely
that viperin expression did not cause a major disruption of lipid
rafts and that budding defect caused by viperin expression was due
to some other effect of viperin and not due to lipid raft disruption.Bud completion and the pinching-off process require fusion of
apposing plasma membranes and viral membranes, leading to fis-
sion of virus bud and bud release. It is possible that lipid rafts may
have two opposite effects on the influenza virus budding process.
Initially, lipid rafts may facilitate bud formation by bringing the
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Fig. 5. Deformed particles are produced in the presence of exogenous cholesterol. MDCK cells were infected (3.0 moi) with WSN virus and at 5 hpi virus-infected cells were
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bither treated with 0.4 mg/ml water soluble cholesterol containing 6 mM MCD (A
egative-stain EM (Barman and Nayak, 2007). Panel A, left picture was taken at 29
as taken at 72,000× magnification. Daisy-chain structures of some virus particles
ud pinching-off process.
iral components to and concentrating the components at the bud-
ing site, as well as causing asymmetry in the membrane bilayers
nd favoring membrane bending and bud initiation (Nayak et al.,
004). However, at the final stage of bud completion, the lipid raft
icrodomain may slow down and regulate bud closure because
f its increased viscosity and rigidity. This idea is supported by the
bservation that exogenous cholesterol increased the TX-100 insol-
bility of raft-associated proteins, inhibited virus release (Barman
nd Nayak, 2007), and produced deformed, and elongated buds
ith multiple incomplete buds attached to each other (Fig. 5).
hese results suggest defective bud scission in the presence of
xcess exogenous cholesterol. The mosaic nature of the viral mem-
rane containing both raft-associated and non-raft-associated lipid
icrodomains may have different functions in the virus budding
rocess involving bud initiation and bud closure. Disruption of lipid
afts at the final stage may facilitate bud closure, thereby increasing
irus release.
. Budding process
Influenza viruses selectively bud from the apical domain of
olarized epithelial cells, which would require the transport of
ll viral components to the budding site, and their interaction
nd assembly either prior to or subsequent to their arrival to the
udding site. As mentioned earlier, transporting viral components
o the budding site requires the involvement of exocytic path-
ay and their components. Similarly, in the assembly process,
ultiple cellular components including actin microfilaments, lipid
afts as well as exocytic pathway play critical role in concentrat-
ng the viral components and providing favorable environment for
heir interaction and formation of sub-viral complexes of higher
rder in the assembly process. The budding process itself requires
hree major steps: bud initiation, bud growth, and bud com-
letion releasing the virus from the host cell membrane. Each
f these steps involves interaction of multiple host and viral
omponents..1. Bud initiation
Bud initiation requires outward bending of the plasma mem-
rane and involves transition of a more planar membrane structureock treated (B). At 12 hpi, released virus particles were purified and examined by
, and portions were further magnified at 72,000× (panel A, right). Panel B picture
l A) released from cells in the presence of exogenous cholesterol indicate defective
to a curved structure at the budding site. Although the structural
nature and biochemical properties as well as the physical forces at
these sites responsible for membrane bending and bud initiation
are unknown, it is likely that both lipid rafts and raft-associated
proteins present at the budding site play an important role in
causing membrane curvature and bud initiation. Lipid rafts causing
asymmetry in lipid bilayers can cause intrinsic curvature of one
lipid monolayer relative to the other monolayer leading to mem-
brane bending (see Nayak and Hui, 2004). Membrane deformation
can be caused by selective transfer of lipids between the lipid
bilayers, interaction of cholesterol into the budding leaflet as well
as hydrolytic cleavage of phosphocholine head groups of sphin-
gomyelin by sphingomyelinase generating smaller head groups
(Holopainen et al., 2000). Additionally, BAR (Bin/Amphiphysin/Rsv)
domain has been shown to cause membrane curvature (Peter et al.,
2004) and is known to be present in a number of proteins involved
in vesicle formation and recycling. However, role of any of these
proteins in influenza virus budding is unknown. In addition to lipid
microdomains, the presence of specific viral proteins including HA,
NA, M2, and M1 proteins may further facilitate membrane bending
(see Nayak and Hui, 2004). Among these, M1 interacting with the
inner leaflet of lipid bilayers is likely to play a critical role in bud
initiation. Clustering of M1 due to M1/M1 interaction underneath
the lipid bilayers can cause outward membrane bending and bud
initiation.
7.2. Bud growth
Bud growth leading to bud maturation is the intermediate stage
between the bud initiation and bud release. Bud growth determines
the size and the morphology of released virus particles. However,
what factors or forces determine and regulate bud growth remains
unclear. For most viruses regardless containing either icosahedral
(e.g. SFV) or helical (e.g. VSV) nucleocapsids, the size of the nucle-
ocapsids determines the size of the virions. However, influenza
viruses are highly pleomorphic and the size of the released particles
can vary from spheroidal, elongated and even filamentous (Fig. 2)
and the content of the nucleocapsids is not the major factor for
bud growth. Influenza virus bud growth appears rather to depend
on two forces, a pulling and a pushing force. The pulling force is
primarily provided by the transmembrane proteins along with M1
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ith the permission of David Hockley of the National Institute of Biological Standard
nd Control at Hertfordshire, UK.
hich are pulling nucleocapsids into the bud. On the other hand,
he cortical actin microfilaments which bind to viral RNPs provide
he pushing force for incorporating the nucleocapsids and M1 into
he bud. Electron tomography analysis of virus buds attached to the
ell surface shows that helical nucleocapsids are perpendicular to
he cell membrane while being incorporated into the buds and that
uds are essentially complete still remaining attached to the cell
embrane and are of similar size (Figs. 6 and 7).
As mentioned earlier, influenza virus particles are highly
leomorphic in shape and size. Basically, there are two types
f pleomorphism observed among influenza viruses: (i) strain-
pecific i.e. strain to strain variation which may also vary depending
n the host cell; (ii) variation within the population of plaque puri-
ed virus in the same cell. Clearly, the genome of the virus strain
s an important factor in determining the particle size and shape
f a specific virus strain (e.g. Udorn vs. WSN). Specific viral genes
nvolved in determining filamentous vs. spheroidal forms have been
dentified (see Section 5). Similarly, role of polarized epithelial cells
nd intact actin microfilaments were found to be critical in main-
aining the filamentous form of Udorn virus. However, the cause
f pleomorphism in plaque purified influenza viruses is not well
nderstood. Whatever may be the viral and cellular factors involved
n viral pleomorphism, these are likely to affect bud growth and
losing and will eventually affect the shape and size of the virus
articles. This is not to state that factors affecting bud closing will
lways affect bud size and bud shape; but factors affecting bud
hape and bud size will always affect bud closing. The viral and
ig. 7. Virus buds at the cell surface by ET. At 12 hpi WSN-infected MDCK cells were
rocessed for thin section and examined by ET. This picture represents one slice
hrough the central region of the virus buds. One can see the parallel arrangement of
he vRNPs inside the bud perpendicular to cell surface. The bud neck (⇒) shows gaps
ndicating possible absence of M1. HA and NA spikes are seen on the bud envelope.ch 143 (2009) 147–161
host factors affecting the size of virus particles will either hinder or
facilitate bud closing.
7.3. Bud closing
Bud closing is the final step for the scission of the bud and
release of the virus particle into the outer environment. Bud closure
would involve fusion of two ends of the apposing viral membranes
as well as that of the apposing cell membranes leading to fission
of the virus bud from the infected cell membrane (Fig. 8). This
would require bringing and holding the apposing membrane ends
next to each other in close proximity so that each end can find its
counterpart causing fusion of corresponding lipid bilayers. Virus
buds would then become separated from the membrane of the
parent infected cell. This model holds that two lipid bilayers are
to be held in very close proximity for fusion to occur. Host and
viral factors could have both positive and negative impact on bud
release. Some factors could interfere in bringing the apposing ends
close to each other and therefore, should be removed. Others could
help in bringing and holding the membrane ends close to each
other for fusion to occur and therefore should be brought to the
pinching-off site. As mentioned above, lipid rafts and the cortical
actin microfilaments, though critical in many aspects of the bud-
ding process, are inhibitory in the final step of bud closing and
therefore should be removed from the pinching-off site. Clearly,
there are other host factors, yet to be identified, which are required
for bringing and holding the apposing viral and cellular membranes
next to each other for facilitating fusion and fission. Among the viral
components, M2 may play critical role in the pinching-off process.
M2 when present in the neck of the bud may aid in bud release
(Schroeder et al., 2005) by bringing non-lipid rafts in this region
(Fig. 8). Absence of M1 protein underneath the lipid bilayers and
absence of spikes on the outer surface may indicate the absence of
lipid rafts (Fig. 8). From CT analysis, such lipid microdomains have
been proposed to be the preferred sites for the bud pinching off
(Harris et al., 2006).
As mentioned earlier, bud closing of influenza virus is very inef-
ficient and only a small fraction of virus buds are released while
the majority of virus buds remain attached to the cell membrane
even though they appear mature (Fig. 6). Both host and virus fac-
tors may be contributing towards the rate limiting step of the
pinching-off process. Influenza virus budding also appears to be
an active, energy-dependent process and metabolic inhibitors such
as antimycin A, CCCP, FCCP, oligomycin as well as ATP analogues
such as ATPS and AMP-PNP inhibited influenza virus budding
(Hui and Nayak, 2001). Therefore, limited energy at the end of
infectious cycle may be a factor for the inefficient release of virus
particles. Among other host factors, actin microfilaments may inter-
fere with bud closing, and conversely, disassembly of cortical actin
microfilaments may facilitate it. This notion is supported by several
observations, including the release of virus particles in abortively
infected HeLa cells (Gujuluva et al., 1994), conversion of filamen-
tous Udorn (H3N2) virus to spherical virus and enhanced release of
WSN and PR8 spherical particles in polarized MDCK cells (Roberts
and Compans, 1998; Simpson-Holley et al., 2002) by microfilament-
disrupting agents.
Similarly, lipid rafts may interfere with bud release, owing
to its increased viscosity and rigidity. Indeed, virus release was
enhanced by cholesterol depletion and virus budding was reduced
by addition of exogenous cholesterol (Barman and Nayak, 2007).
Interestingly, members of the ESCART components and proteins
containing WW domains, which are critical for bud closing of many
viruses (Freed and Mouland, 2006), appeared not to be involved in
influenza virus bud closing (Chen and Lamb, 2008). Similarly, pro-
teasome inhibitors including ubiquitination inhibitors did not affect
influenza virus budding (Hui and Nayak, 2001).
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nd Nayak, 2007), devoid of HA and NA spikes outside and M1 inside the lipid bilay
Scission of influenza virus buds from infected cells is the last
tep in completion of virus life cycle. This step appears to be rate
imiting since morphological analysis by both thin section trans-
ission (Barman and Nayak, data not shown) and scanning EM
Fig. 6) shows that a large number of mature virus particles remain
ttached to the cell membrane and only a relatively small fraction of
irus buds (∼10%) are released. The kinetics of virus release relative
o the presence of virus buds awaits further investigation in order
o understand the cause(s) and mechanism(s) for such inefficient
ud completion.
. Conclusion
Influenza virus assembly and budding are the last steps in the
irus replication process and are critically important to the survival
nd transmission of the virus and to the pathogenesis of diseases.
udding requires transport and assembly of the virus components
t the budding site leading to bud initiation, growth and release.
n this review, we have covered the steps involved in the assem-
ly and budding processes and the roles played by both virus and
ost components in these steps. Although much is known about
he different steps of virus replication including entry, uncoating,
ynthesis of viral RNA and proteins, transport of viral components,
ur knowledge about the process of bud closing and bud release is
ery limited. A better understanding of this important process in
nfluenza virus biology awaits answers to the following questions:1. What are the specific determinants of viral components required
for preferential budding of influenza virus from the apical plasma
membrane of polarized epithelial cells? In addition to HA and NA,
the role of NP in selecting the apical budding site requires further
investigation.hing-off region (neck) is shown to be viral membrane devoid of lipid rafts (Barman
arris et al., 2006) and may contain M2 (Schroeder et al., 2005).
2. How are all the eight specific vRNP segments incorporated into a
single virus bud? Is there a stable complex of eight RNP segments
in the cytoplasm of infected cells outside the virus buds? Why
are there no apparent check points in the budding of infectious
vs. non-infectious viruses? Is bud closure and release a random,
unregulated process? Do the majority of released virus parti-
cles contain eight vRNPs or do the genomic content of individual
particles vary?
3. What is the cause of such a high degree of pleomorphism among
the released virus particles even with the same genomic content?
4. Are there any regulations of bud closing? If not, why are bud
closing and release so inefficient? If so, what are the host and
viral factors involved in regulating bud closing? A more detailed
structural analysis of native and mutant virus particles, as well
as the budding and pinching-off sites on the plasma membrane
by electron tomography would be critical for understanding the
bud release process.
In summary, our knowledge about the roles of host factors in
influenza virus bud closing is critically lacking. A better under-
standing of the influenza virus budding process will not only help
us in identifying new targets for therapeutic intervention against
pandemic and epidemic influenza, but also will facilitate in the pro-
duction of more potent and cheaper vaccines. For example, more
efficient bud closing will produce more virus particles in the pro-
cess of vaccine production and may also produce higher yield of
VLP antigen and thus may lead to better and cheaper vaccines.Acknowledgments
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